Resilience and Equity in Aging, Cancer, and Health (REACH)

Recruiting N/A Interventional Study
Gastric Cancer Colon Cancer Esophageal Cancer Rectal Cancer Pancreatic Cancer Gastrointestinal Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
70 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
257 (estimated)
Sponsor
Dana-Farber Cancer Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients who are age 70+ at time of initial consult at DF/BWCC * Diagnosed with a gastrointestinal cancer, including: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors. * Continuing care at DF/BWCC …
Contacts

Nadine J McCleary, MD, MPH

877-442-3324

NJ_McCleary@dfci.harvard.edu

CONTACT